To further investigate the synergy of the scaffolding LSD1 inhibitor SP2509 with JAKi (Ruxolitinib) regarding the regulation of the intrinsic apoptosis pathway in human ETP-ALL, we performed western blot of pro- and anti-apoptotic proteins. This evidence concerns the gene KDM1A and acute lymphoblastic leukemia.